Related Experiment Video
Updated: Jul 4, 2026
05:17
Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
Published on: April 18, 2025
Positron emission tomography scans obtained for the evaluation of cognitive dysfunction
Daniel H S Silverman1, Lisa Mosconi, Linda Ercoli
1David Geffen School of Medicine, University of California, Los Angeles, CA, USA. dsilver@ucla.edu
Seminars in Nuclear Medicine
|June 3, 2008
Summary
Positron emission tomography (PET) using (18)F-fluorodeoxyglucose aids in diagnosing cognitive impairment and distinguishing neurodegenerative disorders. Early detection via PET can significantly impact patient outcomes as treatments emerge.
Area of Science:
- Neuroimaging
- Neurology
- Nuclear Medicine
Background:
- Cognitive functioning varies widely, with dementia posing diagnostic challenges.
- Neurodegenerative disorders, like Alzheimer's disease, are common causes of dementia.
- These disorders cause significant brain metabolism alterations with severe consequences.
Purpose of the Study:
- To highlight the role of neuroimaging, specifically positron emission tomography (PET), in evaluating cognitive impairment.
- To discuss the diagnostic and prognostic utility of (18)F-fluorodeoxyglucose PET in identifying neurodegenerative disorders.
- To explore the potential impact of early PET-detected diagnosis on future treatments.
Main Methods:
- Utilizing (18)F-fluorodeoxyglucose (FDG) as a radiopharmaceutical for brain PET scans.
- Analyzing cerebral metabolism changes detectable by FDG-PET.
- Considering other radiotracers for assessing brain changes in cognitive impairment.
Main Results:
- FDG-PET scans reveal alterations in brain metabolism associated with cognitive impairment.
- PET imaging demonstrates diagnostic and prognostic value in differentiating neurodegenerative diseases.
- Early-stage metabolic changes are detectable, aiding in timely diagnosis.
Conclusions:
- PET imaging is crucial for diagnosing cognitive impairment and distinguishing between various causes of decline.
- Early and accurate diagnosis through PET facilitates the development and application of preventive and disease-modifying treatments.
- PET's role is vital in mitigating the impact of dementia and related disorders.
Related Concept Videos
01:29Positron Emission Tomography
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...
01:25Imaging Studies II: Positron Emission Tomography and Scintigraphy
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
Fundamental Principles of PET
01:14Brain Imaging
Brain imaging technologies provide critical insights into both the structure and function of the human brain, enabling medical professionals and researchers to diagnose, study, and treat neurological disorders or psychiatric disorders more effectively.
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic Stimulation (TMS).
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic Stimulation (TMS).
01:13Radiological Investigation III: Pulmonary Angiogram and PET Scan
Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
01:27Imaging Studies III: Computed Tomography
DefinitionComputed Tomography (CT) of the genitourinary (GU) tract is a non-invasive imaging modality that utilizes X-rays and computer processing to generate detailed cross-sectional images of the urinary system, encompassing the kidneys, ureters, bladder, and adjacent structures such as the adrenal glands.PurposeCT scans of the GU tract serve several diagnostic and therapeutic purposes, including:Diagnosis of Urinary Tract Diseases: Detects kidney stones, tumors, cysts, and congenital...